Short-term Efficacy of Apraclonidine Hydrochloride Added to Maximum-tolerated Medical Therapy for Glaucoma
- 1 October 1995
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 120 (4) , 423-432
- https://doi.org/10.1016/s0002-9394(14)72655-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Reformulation and Drop Size of Apraclonidine HydrochlorideAmerican Journal of Ophthalmology, 1992
- Additive Effect of 1% Apraclonidine Hydrochloride to Nonselective β-BlockersOphthalmology, 1991
- Cardiovascular and Intraocular Pressure Effects and Plasma Concentrations of ApraclonidineArchives of Ophthalmology (1950), 1990
- A Limited Comparison of Apraclonidine's Dose Response in Subjects with Normal or Increased Intraocular PressureAmerican Journal of Ophthalmology, 1989
- Adjunctive Glaucoma TherapyOphthalmology, 1989
- ApraclonidineArchives of Ophthalmology (1950), 1988
- Prevention of the Rise in Intraocular Pressure Following Neodymium-YAG Posterior Capsulotomy Using Topical 1% ApraclonidineArchives of Ophthalmology (1950), 1988
- ALO 2145 Reduces the Intraocular Pressure Elevation after Anterior Segment Laser SurgeryOphthalmology, 1988
- Effects of Topical ALO 2145 (p-Aminoclonidine Hydrochloride) on the Acute Intraocular Pressure Rise After Argon Laser IridotomyArchives of Ophthalmology (1950), 1987
- The Safety and Efficacy of Topical 1% ALO 2145 (p-Aminoclonidine Hydrochloride) in Normal VolunteersArchives of Ophthalmology (1950), 1987